SCHEMBL16293302

SCHEMBL16293302

C=CCNCC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1.OCC1CCN(CC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)C1

nearest known ligand 0.81

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
HTT P42858 1/20 0.59
KMT2A Q03164 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14965176 0.91 POLB (0.60) POLBHTTKMT2A
SCHEMBL14965072 0.82 POLB (0.62) POLBHTTKMT2A
SCHEMBL14964774 0.82 POLB (0.66) POLBHTTKMT2A
SCHEMBL16293323 0.81 POLB (0.61) POLBHTTKMT2A
SCHEMBL14964827 0.81 POLB (0.53) POLBHTTKMT2A
SCHEMBL17599008 0.81 KMT2A (0.77) POLBHTTKMT2A
SCHEMBL14965055 0.79 POLB (0.65) POLBHTTKMT2A
SCHEMBL14965006 0.79 POLB (0.66) POLBHTTKMT2A
SCHEMBL17599009 0.78 ADRB3 (0.58)
SCHEMBL14964970 0.78 POLB (0.59) POLBHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140371203-A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors XENTION LIMITED (GB) 2014-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371203-A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors KCNA3, KCNJ1, KCNJ11 POLB 3507/4885HTT 2759/4885KMT2A 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.